[go: up one dir, main page]

SE8704093L - Terapeutiska medel och anvendning derav - Google Patents

Terapeutiska medel och anvendning derav

Info

Publication number
SE8704093L
SE8704093L SE8704093A SE8704093A SE8704093L SE 8704093 L SE8704093 L SE 8704093L SE 8704093 A SE8704093 A SE 8704093A SE 8704093 A SE8704093 A SE 8704093A SE 8704093 L SE8704093 L SE 8704093L
Authority
SE
Sweden
Prior art keywords
therapeutic agents
isopropylamino
pyrrol
phenoxy
propanol
Prior art date
Application number
SE8704093A
Other languages
English (en)
Other versions
SE8704093D0 (sv
Inventor
F Ostermayer
J Jaekel
N Veillon
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4235/86A external-priority patent/CH668185A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8704093D0 publication Critical patent/SE8704093D0/sv
Publication of SE8704093L publication Critical patent/SE8704093L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8704093A 1986-10-24 1987-10-21 Terapeutiska medel och anvendning derav SE8704093L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.
CH17887 1987-01-19
CH92687 1987-03-12
CH92587 1987-03-12

Publications (2)

Publication Number Publication Date
SE8704093D0 SE8704093D0 (sv) 1987-10-21
SE8704093L true SE8704093L (sv) 1988-04-25

Family

ID=27427782

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704093A SE8704093L (sv) 1986-10-24 1987-10-21 Terapeutiska medel och anvendning derav

Country Status (16)

Country Link
EP (1) EP0265388A1 (sv)
KR (1) KR880005094A (sv)
AT (1) ATA281087A (sv)
BE (1) BE1002060A3 (sv)
DE (1) DE3735641A1 (sv)
DK (1) DK554887A (sv)
FI (1) FI874643A (sv)
FR (1) FR2605629A1 (sv)
GB (1) GB2197315A (sv)
GR (1) GR871634B (sv)
HU (1) HUT45492A (sv)
IE (1) IE872860L (sv)
NL (1) NL8702533A (sv)
NO (1) NO874425L (sv)
PT (1) PT85976B (sv)
SE (1) SE8704093L (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
JPH02131465A (ja) * 1988-07-18 1990-05-21 Nippon Tokushu Noyaku Seizo Kk 1−フエニルピロール類及び除草剤としての利用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204241A1 (es) * 1973-03-09 1975-12-10 Ciba Geigy Ag Procedimiento para preparar compuestos derivados del 1-pirrolil(1)-fenoxi-2-hidroxi-3-alquilamino-propano y del 1-pirrolil-(1)-fenoxi-3-hidroxi-3-morfolino-propano
DE2835438A1 (de) * 1978-08-12 1980-03-06 Basf Ag Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung

Also Published As

Publication number Publication date
PT85976B (de) 1990-01-19
FR2605629A1 (fr) 1988-04-29
GR871634B (en) 1988-02-24
FI874643A0 (fi) 1987-10-21
SE8704093D0 (sv) 1987-10-21
IE872860L (en) 1988-04-24
DK554887D0 (da) 1987-10-23
ATA281087A (de) 1989-01-15
KR880005094A (ko) 1988-06-28
BE1002060A3 (fr) 1990-06-12
PT85976A (de) 1987-11-01
NO874425L (no) 1988-04-25
HUT45492A (en) 1988-07-28
GB2197315A (en) 1988-05-18
DK554887A (da) 1988-04-05
NL8702533A (nl) 1988-05-16
DE3735641A1 (de) 1988-04-28
FI874643A (fi) 1988-04-25
EP0265388A1 (de) 1988-04-27
NO874425D0 (no) 1987-10-23

Similar Documents

Publication Publication Date Title
DE3382458D1 (de) Haarwuchsmittel.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK581889A (da) Antiatherosclerotiske diarylforbindelser
IT1224405B (it) Composti attivi sul sistema cardiovascolare
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO168644C (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-(pyrrol-1-yl)pyridinaminer
SE8704093D0 (sv) Terapeutiska medel och anvendning derav
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
BR8009059A (pt) Administracao de substancia medicas ativas
DK197689D0 (da) Pyridazinderivater
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
IT1207583B (it) Composizione farmaceutica comprendente un complesso organico dello zinco e procedimento per preparate la sostanza attiva.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO870834L (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
DE69113437D1 (de) Therapeutische Mittel für diabetisches Gangrän.
DK299983D0 (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.
PT87077A (pt) Terc-butylamino-3-(phenyl-2:-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8704093-7

Effective date: 19910501